- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 275/03 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Patent holdings for IPC class C07D 275/03
Total number of patents in this class: 171
10-year publication summary
|
8
|
20
|
19
|
15
|
13
|
16
|
11
|
10
|
7
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2169 |
6 |
| Bayer Cropscience AG | 1846 |
6 |
| Blade Therapeutics, Inc. | 15 |
5 |
| Bayer AG | 3495 |
4 |
| Abbvie Inc. | 1836 |
4 |
| Epizyme, Inc. | 359 |
4 |
| Romark Laboratories L.C. | 44 |
4 |
| Disarm Therapeutics, Inc. | 55 |
4 |
| Inipharm, Inc. | 31 |
4 |
| BASF SE | 21303 |
3 |
| Board of Regents, The University of Texas System | 6102 |
3 |
| Duke University | 3184 |
3 |
| Alexion Pharmaceuticals, Inc. | 648 |
3 |
| Chiesi Farmaceutici S.p.A. | 959 |
3 |
| Dompé Farmaceutici S.p.A. | 298 |
3 |
| Eli Lilly and Company | 4089 |
3 |
| IsoPlexis Corporation | 116 |
3 |
| Theravance Biopharma R&D IP, LLC | 407 |
3 |
| Calico Life Sciences LLC | 107 |
3 |
| Psyched Wellness Ltd. | 19 |
3 |
| Other owners | 97 |